Kim Schrier actually said...
With current rates of disease, my assessment is that the risk of the disease, whether it is the acute or the multisystem inflammatory syndrome or long COVID, far outweigh the remote risk of mild myocarditis that might be associated with the second dose of an mRNA vaccine.
06/15/2021